Your browser doesn't support javascript.
loading
Contemporary treatment patterns and survival of cervical cancer patients in Ethiopia.
Deressa, Biniyam Tefera; Assefa, Mathewos; Tafesse, Ephrem; Kantelhardt, Eva Johanna; Soldatovic, Ivan; Cihoric, Nikola; Rauch, Daniel; Jemal, Ahmedin.
Afiliação
  • Deressa BT; Adama Hospital Medical College, Adama, Ethiopia. biniyamtefera.md@gmail.com.
  • Assefa M; Department of Clinical Oncology, College of Health Sciences, Addis Ababa university, Addis Ababa, Ethiopia.
  • Tafesse E; College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  • Kantelhardt EJ; Department of Gynaecology and Institute of Clinical Epidemiology, Martin Luther University, Halle an der Saale, Germany.
  • Soldatovic I; Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Beograd, Serbia.
  • Cihoric N; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Rauch D; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Jemal A; Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.
BMC Cancer ; 21(1): 1102, 2021 Oct 13.
Article em En | MEDLINE | ID: mdl-34645407
ABSTRACT

BACKGROUND:

Cervical cancer is the second commonly diagnosed cancer and the second leading cause of cancer death in women in Ethiopia, with rates among the highest worldwide. However, there are limited data on cervical cancer treatment patterns and survival in the country. Herein, we examine treatment patterns and survival of cervical cancer patients treated in Tikur Anbessa Hospital Radiotherapy Center (TAHRC), the only hospital with radiotherapy facility in the country.

METHODS:

Women with histologically verified cervical cancer who were seen in 2014 (January 1, 2014 to December 31, 2014) at TAHRC were included. Information about clinical characteristics and treatments were extracted from the patients' medical record files. The information on vital status was obtained from medical chart and through telephone calls.

RESULT:

Among 242 patients included in the study, the median age at diagnosis was 48 years. The median waiting time for radiotherapy was 5.6 months (range 2 to 9 months). Stage migration occurred in 13% of patients while waiting for radiotherapy. Consequently, the proportion of patients with stage III or IV disease increased from 66% at first consultation to 74% at the initiation of radiotherapy. Among 151 patients treated with curative intent, only 34 (22.5%) of the patients received concurrent chemotherapy while the reaming patients received radiotherapy alone. The 5-year overall survival rate was 28.4% (20.5% in the worst-case scenario). As expected, survival was lower in patients with advanced stage at initiation of radiotherapy and in those treated as palliative care.

CONCLUSION:

The survival of cervical cancer patients remains low in Ethiopia because of late presentation and delay in receipt of radiotherapy, leading to stage migration in substantial proportion of the cases. Concerted and coordinated multisectoral efforts are needed to promote early presentation of cervical cancer and to shorten the unacceptable, long waiting time for radiotherapy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article